Lifitegrast Eye Drops in Healthy Subjects：Phase I Study

Clinical trial NCT07040826 · COMPLETED

Trial details

NCT number: NCT07040826
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2022-12-06
Primary completion: 2022-12-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.